Where does Asarina Pharma AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Asarina Pharma AB ranks #44,856 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Asarina Pharma AB hold?

Asarina Pharma AB holds 5 US utility patents granted between 2017 and 2022, spanning 6 technology areas.

What is Asarina Pharma AB's Innovation Score?

Asarina Pharma AB has an Innovation Score of 24.3 out of 100 (14th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Asarina Pharma AB's patent grant rate increasing or decreasing?

Asarina Pharma AB's recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Asarina Pharma AB's patents?

Asarina Pharma AB's patents average 12.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Asarina Pharma AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Asarina Pharma AB

Q: What technology areas does Asarina Pharma AB focus on?

Asarina Pharma AB's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 5 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Asarina ranks #44,856 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.

#44,856
of 49,997 US assignees by volume: 14th percentile
by Innovation Score (24.3/100): 12.0
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R44856 · Foreign Corporation #44,856 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
LOWER-Q #44,856/49,997
PHOTO-FINISH Arysta Lifescience…
CPC-NARROW A61K · 6 areas
INNOV-THIN 24.3/100
CLAIMS-RICH 12.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Arysta Lifescience North America, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Asarina Pharma AB · this assignee

24
3D Lighting… · lowest

7

What this shows Asarina's Innovation Score is 24.3/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Asarina's grants concentrate

Asarina Pharma AB is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2017. By volume, Asarina sits between Arysta Lifescience North America, LLC and Ashima Ltd..

Asarina's three-year grant acceleration

Asarina Pharma AB shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Arysta Lifescienc…

5
Asahi Fiber Glass

5
Asahi FR R&D

5
Asahi Shipping

5
Ascension Texas

5
Ascom (Sweden) AB

5
Ascon Systems Hol…

5
Ashima

5
Asarina Pharma AB ◀

5

What this shows Asarina holds 5 patents at rank #44,625, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Asarina

By rank, the assignees closest to #44,625 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Asarina's primary technology class.

Asarina's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 14th percentile higher than 14% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Asarina Pharma AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	20.0%
2021	3	60.0%
2022	1	20.0%

Which technologies does Asarina Pharma AB patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

C07J - Steroids 1

B01D - Separation 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#44,856

of 49,997 tracked assignees

Innovation Score

24.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Asarina Pharma AB's patent record in context - here's where to go next.

Asarina Pharma AB's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #44,856 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Asarina Pharma AB against Arysta Lifescience North America, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.